The Food and Drug Administration (FDA) is holding a public meeting on May 15, 2025, to discuss the implementation of the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA). This meeting aims to gather input from various parties like patients, caregivers, consumer groups, academia, and the pharmaceutical industry to inform a report for Congress. Participants can attend in person at the FDA White Oak Campus in Silver Spring, MD, or virtually via Zoom. Those interested in commenting must register by May 1, 2025, and submit their comments by June 13, 2025.
Simple Explanation
The FDA is having a big meeting to talk about making sure medicines for kids are safe and work well. They want to hear from lots of people like parents, doctors, and medicine makers to help them make a report for the government.